GlassScriptPhysician profile
Timothy J Kanter
NPI 1083706535
$630,270.05
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247K · 2020: $105K · 2021: $132K · 2022: $146K · 2023: $84.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $408,975.26 | 2019-2022 | |
| Gilead Sciences, INC. | $93,890.79 | 2019-2023 | Biktarvy |
| Merck Sharp & Dohme LLC | $69,238.67 | 2019-2022 | |
| Janssen Products, LP | $51,777.36 | 2019 | |
| Theratechnologies INC. | $3,374.28 | 2019-2022 | |
| Janssen Biotech, INC. | $1,166.93 | 2019-2022 | |
| Glaxosmithkline, LLC. | $975.41 | 2019 | |
| Sanofi-Aventis U.S. LLC | $300.00 | 2021 | |
| Napo Pharmaceuticals INC | $241.61 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $184.60 | 2019 | |
| Shionogi INC | $124.54 | 2022 | |
| Allergan, INC. | $20.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Kanter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.